Next Article in Journal
Intra-/Interobserver Agreement of Enhancement Pattern for Pancreatic Head Lesions Using Contrast-Enhanced Ultrasound: According to EFSUMB Guidelines
Next Article in Special Issue
Gold Nanoparticles-Coated SU-8 for Sensitive Fluorescence-Based Detections of DNA
Previous Article in Journal
Bayesian Estimation of Combined Accuracy for Tests with Verification Bias
Article Menu

Export Article

Diagnostics 2012, 2(1), 1-1; doi:10.3390/diagnostics2010001

Special Issue: Microfluidic Lab-on-a-Chip Platforms for High-Performance Diagnostics
Jens Ducrée
Guest Editor, Biomedical Diagnostics Institute, National Centre of Sensor Research, School of Physical Sciences, Dublin City University, Glasnevin, Dublin 9, Ireland; Tel: +353-1-700-7870
Received: 20 March 2012 / Published: 20 March 2012

The field of microfluidics has seen breath-taking progress since its beginnings in the 1980s and early 1990s. While much of the initial work was a by-product of mainstream micro-electro-mechanical systems (MEMS) and silicon based fabrication schemes, soon a specialized research field developed. Over the last decade a strong, highly interdisciplinary microfluidics community emerged with roots in classical silicon microfabrication as well as chemistry, physics, biotechnology, medicine and various engineering disciplines.

This special issue will emphasize microfluidic lab-on-a-chip platforms which are deemed a key enabler for high-performance future diagnostics. Amongst the techno-scientific advantages which are intrinsic to these miniaturised systems are: laminar flow conditions; enhanced, diffusion-advection controllable mixing and reaction kinetics; low sample and reagent volumes; availability of capillary flow and surface tension related effects; amenability for large-scale combinatorial assays; and scale matching on the micro-to-nano-range for large biomolecules and cells. On a system level, lab-on-a-chip technologies offer user-friendly sample-to-answer automation, single-use cartridges for potentially biohazardous samples, compact footprint, and simplified instrumentation. These features empower use in decentralized point-of-care settings, for instance as portable devices in doctor’s offices, ambulances, patient self-testing at home and global diagnostics. Lab-on-a-chip platforms also bear a high potential to leverage next-generation companion diagnostics for personalized (stratified) medicine.

Diagnostics EISSN 2075-4418 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top